We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Next-Generation Models Launched for Sediment Urinalysis Testing

By LabMedica International staff writers
Posted on 05 Oct 2015
Print article
The UF-5000 Fully Automated Analyzer of Formed Elements in Urine
The UF-5000 Fully Automated Analyzer of Formed Elements in Urine (Photo courtesy of Sysmex America, Inc.)
Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders and a new model for this analysis has just been launched.

Urine testing is divided into urine chemistry, a primary test employing urine test paper, and urine sediment analysis, secondary testing to provide a more detailed analysis of specimens that have been determined to be abnormal during urine chemistry.

Urine sediment analysis is an important test used in diagnosing renal disease and urinary tract disorders. Clinical laboratory technologists use microscopes to observe (microscope testing), classify and measure formed elements in the urine, including red blood cells, white blood cells and bacteria. The ability to perform automated quantitative analysis of formed elements in the urine by using the flow cytometry method was established almost 20 years ago.

Sysmex Corporation (Kobe, Japan) has launched its new products in the sediment urinalysis testing field, the UF-5000/4000/3000 fully automated analyzers of formed elements in urine. The instruments will be rolled out successively on a global scale, beginning with the Japanese market in September 2015. The new models employ blue lasers and other technologies to improve precision and fraction1 and can be used for testing urine and other bodily fluids.

The modular concept is employed to flexibly enable instruments to be added as the number of specimens grows. This concept also allows for future linkage with urine chemistry analyzers and for transport connections among multiple devices at large-scale facilities. Designed to optimize customer usability, the models employ the “Silent Design 3” concept and have simple operating panels. Some RFID4 cassette-type reagents are used to simplify reagent management and replacement.

To contribute to customer operating efficiency, the models are provided in combination with the Urinalysis Work Area Information Management System (U-WAM), which enables urinalysis departments to centrally manage test results. By continuing to provide valuable products in the urinalysis field going forward, Sysmex aims to establish a leading global position in this field of testing.

Related Links:

Sysmex Corporation


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.